Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6543
    +0.0020 (+0.30%)
     
  • OIL

    84.15
    +0.58 (+0.69%)
     
  • GOLD

    2,356.40
    +13.90 (+0.59%)
     
  • Bitcoin AUD

    98,598.46
    +343.73 (+0.35%)
     
  • CMC Crypto 200

    1,387.36
    -9.17 (-0.66%)
     
  • AUD/EUR

    0.6095
    +0.0022 (+0.37%)
     
  • AUD/NZD

    1.0976
    +0.0019 (+0.17%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,130.32
    +51.46 (+0.64%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    18,011.84
    +94.56 (+0.53%)
     
  • Hang Seng

    17,648.57
    +364.03 (+2.11%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Trade Alert: The Of CardieX Limited (ASX:CDX), Paul Cozzi, Has Just Spent AU$459k Buying Shares

Investors who take an interest in CardieX Limited (ASX:CDX) should definitely note that insider Paul Cozzi recently paid AU$0.027 per share to buy AU$459k worth of the stock. That's a very solid buy in our book, and increased their holding by a noteworthy 21%.

Check out our latest analysis for CardieX

The Last 12 Months Of Insider Transactions At CardieX

In fact, the recent purchase by Paul Cozzi was the biggest purchase of CardieX shares made by an insider individual in the last twelve months, according to our records. That implies that an insider found the current price of AU$0.027 per share to be enticing. That means they have been optimistic about the company in the past, though they may have changed their mind. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for CardieX share holders is that an insider was buying at near the current price. Paul Cozzi was the only individual insider to buy shares in the last twelve months. Notably Paul Cozzi was also the biggest seller.

ADVERTISEMENT

The chart below shows insider transactions (by individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

ASX:CDX Recent Insider Trading, February 1st 2020
ASX:CDX Recent Insider Trading, February 1st 2020

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership of CardieX

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. CardieX insiders own about AU$3.9m worth of shares. That equates to 19% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Does This Data Suggest About CardieX Insiders?

It's certainly positive to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. But on the other hand, the company made a loss last year, which makes us a little cautious. Given that insiders also own a fair bit of CardieX we think they are probably pretty confident of a bright future. Along with insider transactions, I recommend checking if CardieX is growing revenue. This free chart of historic revenue and earnings should make that easy.

Of course CardieX may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.